CA17140 Related Publications

This page lists international publications related to CA17140 which acknowledge the Action but cannot be classified as Action papers either for wrong acknowledgment citation or because not featuring at least 2 co-authors belonging to different COST Countries, or because the authors forgot to acknowledge the action in the Acknowledgment section.



  • Lopes-Nunes J, Lifante J, Shen Y, Ximendes EC, Jaque D, Iglesias-de la Cruz MC, Cruz C. Biological studies of an ICG-tagged aptamer as drug delivery system for malignant melanoma. Eur J Pharm Biopharm. 2020;154:228-235. Copyright (C) Elsevier B.V. (https://doi.org/10.1016/j.ejpb.2020.07.018).




  •  Tiwari AP, Thorat ND, Pricl S, Patil RM, Rohiwal S, Townley H. Bioink: a 3D-bioprinting tool for anticancer drug discovery and cancer management. Drug Discov Today. 2021;26(7):1574-1590. Copyright (C) Elsevier B.V. (https://doi.org/10.1016/j.drudis.2021.03.010).

  • Khot VM, Salunkhe AB, Pricl S, Bauer J, Thorat ND, Townley H. Nanomedicine-driven molecular targeting, drug delivery, and therapeutic approaches to cancer chemoresistance. Drug Discov Today. 2021;26(3):724-739 Copyright (C) Elsevier B.V. (https://doi.org/110.1016/j.drudis.2020.12.016)

  • Aulic S, Marson D, Laurini E, Skoko N, Fermeglia M, Pricl S. Regulatory, safety, and toxicological concerns of nanomaterials with their manufacturing issues. In Nano-pharmacokinetics and theranostics: advancing cancer therapy, Nanasaheb D. Thorat and Nitesh Kumar Editors, Academic Press. Chapter 6, pp. 93-115 (2021). Copyright (C) 2020 Elsevier B.V. (https://doi.org/10.1016/B978-0-323-85050-6.00002-5)


  • Garaiova Z, Melikishvili S, Michlewska S, Ionov M, Pedziwiatr-Werbicka E, Waczulikova I, Hianik T, Gomez-Ramirez R, de la Mata FJ, Bryszewska M. Dendronized gold nanoparticles as carriers for gp160 (HIV-1) peptides: biophysical insight into complex formation. Langmuir. 2021;37(4):1542-1550. Copyright (C) 2021 The American Chemical Society (https://doi.org/10.1021/acs.langmuir.0c03159)


  • Fernandes AR, Lima JC, Rodríguez L. Aggregation versus biological activity in Gold(I) complexes. An unexplored concept. Inorg Chem. 2021;60(24):18753-18763. Copyright (C) 2021 The American Chemical Society (https://doi.org/10.1021/acs.inorgchem.1c02359)




  • Kuzminac I, Ćelić A, Bekić S, Kojić V, Savić M, Ignjatović N. Hormone receptor binding, selectivity and cytotoxicity of steroid D-homo lactone loaded chitosan nanoparticles for the treatment of breast and prostate cancer cells. Colloids and Surfaces B: Biointerfaces, 2022,112597 (https://doi.org/10.1016/j.colsurfb.2022.112597).





    • Hovorková M, Červený J, Bumba L, Pelantová H, Cvačka J, Křen V, Renaudet O, Goyard D, Bojarová P. Advanced high-affinity glycoconjugate ligands of galectins. Bioorg Chem. 2023 Feb;131:106279. Copyright (C) Elsevier B.V. (https://doi.org/10.1016/j.bioorg.2022.106279)

    • Figueiredo J, Carreira-Barral I, Quesada R, Mergny JL, Cruz C. Synthesis and evaluation of 2,9-disubstituted-1,10-phenanthroline derivatives as G-quadruplex binders. Bioorg Med Chem. 2022;73:116971. Copyright (C) 2022 Elsevier B.V. (https://doi.org/10.1016/j.bmc.2022.116971).



     

    IMPORTANT NOTICE: CA17140 publications must report the following official sentence in the acknowledgment section:

    This article/publication is based upon work from COST Action CA 17140 "Cancer Nanomedicine from the Bench to the Bedside" supported by COST (European Cooperation in Science and Technology).

     

    All applicants must carefully read the funding rules detailed on the COST website and acknowledge COST as a funding source. The acknowledgment shall follow the COST guidelines on visual identity.

    Visual identity - COST – available here

    European Cooperation in Science and Technology (COST) logo
    Funded by the European Union